APA (7th ed.) Citation

Fujiwara, Y., Masago, K., Matsuzawa, R., Yamaguchi, T., Watanabe, N., Shimizu, J., . . . Horio, Y. (2024). Long-Term Response of Lorlatinib to Leptomeningeal Metastasis in Patients with Anaplastic Lymphoma Kinase Fusion Positive Non-Small Lung Cancer: A Case Report. Case Reports in Oncology, 17(1), 942. https://doi.org/10.1159/000540445

Chicago Style (17th ed.) Citation

Fujiwara, Yutaka, Katsuhiro Masago, Reiko Matsuzawa, Teppei Yamaguchi, Naohiro Watanabe, Junichi Shimizu, Eiichi Sasaki, and Yoshitsugu Horio. "Long-Term Response of Lorlatinib to Leptomeningeal Metastasis in Patients with Anaplastic Lymphoma Kinase Fusion Positive Non-Small Lung Cancer: A Case Report." Case Reports in Oncology 17, no. 1 (2024): 942. https://doi.org/10.1159/000540445.

MLA (9th ed.) Citation

Fujiwara, Yutaka, et al. "Long-Term Response of Lorlatinib to Leptomeningeal Metastasis in Patients with Anaplastic Lymphoma Kinase Fusion Positive Non-Small Lung Cancer: A Case Report." Case Reports in Oncology, vol. 17, no. 1, 2024, p. 942, https://doi.org/10.1159/000540445.